BIM
CLCD

Bogle Investment Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Bogle Investment Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-123,503
Closed -$4.5M – 442
2016
Q4 		$4.5M Buy
+123,503
New +$4.37M 0.31% 106

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Bogle Investment Management's CLCD Position: Q1 2017 in Review

Bogle Investment Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 123,503 shares — an estimated $4.5M sold.

Bogle Investment Management first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $4.5M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Bogle Investment Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Bogle Investment Management sold 123,503 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $4.5M.
  • Bogle Investment Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Bogle Investment Management's CoLucid Pharmaceuticals, Inc. position peaked at $4.5M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Bogle Investment Management's 13F filing for Q1 2017, filed 12 May 2017.